Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman’s Disease

15 August 2020 : Clinical Research

Chao Hu^1AE, Yan Zou^1BF*, Jing Pan^1BD, Jiliang Yang^1DF, Tianyou Yang^1AG, Tianbao Tan^1CE, Jiahao Li^1CG

DOI: 10.12659/MSM.924783

Med Sci Monit 2020; 26:e924783

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Immunohistochemistry. The brown color indicated positive immunostaining of CD138.

Back to the Article